11 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
product candidates on animals before initiating clinical trials involving humans. Animal testing activities have been the subject of controversy
8-K
EX-1.1
1b7o6
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
8-K
EX-1.1
863 7yb9tvwxql
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
dlwugumvf0qg
23 Apr 19
Moleculin Announces $15.0 Million Registered Direct Offering
9:34pm
8-K
EX-1.1
ezp2ot5m
28 Mar 19
Moleculin Announces Proposed Underwritten Public Offering
6:18am
- Prev
- 1
- Next